Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
RATIONALE: Vaccines may help the body build an effective immune response to kill cytomegalovirus infections. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients who have undergone a donor stem cell transplant and have cytomegalovirus infection that has not responded to therapy.
Epistemonikos ID: c7b76b911e45ffd1ab19678d0e20460d8755818b
First added on: May 04, 2024